The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relapse-free survial and target identification to enhance response with neoadjuvant and adjuvant dabrafenib + trametinib (D+T) treatment compared to standard-of-care (SOC) surgery in patients (pts) with high-risk resectable BRAF-mutant metastatic melanoma.
 
Jennifer Ann Wargo
Leadership - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Honoraria - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Consulting or Advisory Role - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Speakers' Bureau - Novartis; Genetech
Research Funding - BMS; Genetech; Novartis; GSK (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Peter A. Prieto
No Relationships to Disclose
 
Miles Cameron Andrews
Research Funding - Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics
 
Phillip Andrew Futreal
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - immatics; Lion Biotechnologies
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Genentech (Inst)
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Isabella Claudia Glitza
Travel, Accommodations, Expenses - Lilly
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Janice N. Cormier
No Relationships to Disclose
 
Jeffrey Edwin Lee
No Relationships to Disclose
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - Dava Oncology; PCME, Rockpointe; PlatformQ Health
Consulting or Advisory Role - Amgen; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb (Mexico); Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Mexico); Merck
 
Lauren Simpson
No Relationships to Disclose
 
Elizabeth M. Burton
No Relationships to Disclose
 
Roland L. Bassett
No Relationships to Disclose
 
Merrick I. Ross
No Relationships to Disclose
 
Jeffrey E. Gershenwald
Consulting or Advisory Role - Castle Biosciences; Merck
Patents, Royalties, Other Intellectual Property - mercator therapeutics
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Scott Eric Woodman
No Relationships to Disclose